Serial Evaluations of Myocardial Infarct Size After Alcohol Septal Ablation in Hypertrophic Cardiomyopathy and Effects of the Changes on Clinical Status and Left Ventricular Outflow Pressure Gradients

American Journal of Cardiology

Volumn 101, Issue 9, 2008, Pages 1328-1333

  Aqel, Raed A ^a   Hage, Fadi G ^a   Zohgbi, Gilbert J ^a   Tabereaux, Paul B ^a   Lawson, David ^a   Heo, Jaekyeong ^a   Perry, Gilbert ^a   Epstein, Andrew E ^a   Dell' Italia, Louis J ^a   Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRIC ACID DERIVATIVE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE PERFUSION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRESSURE GRADIENT; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CARDIOMYOPATHY, HYPERTROPHIC; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ETHANOL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION; VENTRICULAR PRESSURE;

EID: 43049092570     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.12.042     Document Type: Article

References (30)

1. Alam M., Dokainish H., and Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 19 (2006) 319-327
2. Knight C.J. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart 92 (2006) 1339-1344
3. Fernandes V.L., Nagueh S.F., Wang W., Roberts R., and Spencer III W.H. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-the Baylor experience (1996-2002). Clin Cardiol 28 (2005) 124-130
4. Keng F.Y., Chang S.M., Cwajg E., He Z.X., Lakkis N.M., Nagueh S.F., Spencer III W.H., and Verani M.S. Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol 9 (2002) 594-600
5. Lerch H., Schafers M., Gietzen F., Schafers K., Kuwert T., Kuhn H., and Schober O. Myocardial perfusion and metabolism after transcoronary ablation of septum hypertrophy (TASH) in hypertrophic obstructive cardiomyopathy. Nuklearmedizin 36 (1997) 218-222
6. McCann G.P., Van Dockum W.G., Beek A.M., Nijveldt R., Ten Cate F.J., Ten Berg J.M., and Van Rossum A.C. Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 99 (2007) 563-567
7. Hage F.G., Dubovsky E.V., Heo J., and Iskandrian A.E. Outcome of patients with adenosine-induced ST-segment depression but with normal perfusion on tomographic imaging. Am J Cardiol 98 (2006) 1009-1011
8. Sasson Z., Yock P.G., Hatle L.K., Alderman E.L., and Popp R.L. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 11 (1988) 752-756
9. Cannon III R.O., Dilsizian V., O'Gara P.T., Udelson J.E., Tucker E., Panza J.A., Fananapazir L., McIntosh C.L., Wallace R.B., and Bonow R.O. Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy. Circulation 85 (1992) 1039-1045
10. Pedone C., Biagini E., Galema T.W., Vletter W.B., and ten Cate F.J. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy. J Am Soc Echocardiogr 19 (2006) 982-986
11. Nagueh S.F., Lakkis N.M., He Z.X., Middleton K.J., Killip D., Zoghbi W.A., Quinones M.A., Roberts R., Verani M.S., Kleiman N.S., and Spencer III W.H. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 32 (1998) 225-229
12. Schulz-Menger J., Strohm O., Waigand J., Uhlich F., Dietz R., and Friedrich M.G. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 101 (2000) 1764-1766
13. van Dockum W.G., ten Cate F.J., ten Berg J.M., Beek A.M., Twisk J.W., Vos J., Hofman M.B., Visser C.A., and van Rossum A.C. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43 (2004) 27-34
14. van Dockum W.G., Beek A.M., ten Cate F.J., ten Berg J.M., Bondarenko O., Gotte M.J., Twisk J.W., Hofman M.B., Visser C.A., and van Rossum A.C. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111 (2005) 2503-2508
15. White R.D., Obuchowski N.A., Gunawardena S., Lipchik E.O., Lever H.M., Van Dyke C.W., and Lytle B.W. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. Am J Card Imaging 10 (1996) 1-13
16. Valeti U.S., Nishimura R.A., Holmes D.R., Araoz P.A., Glockner J.F., Breen J.F., Ommen S.R., Gersh B.J., Tajik A.J., Rihal C.S., Schaff H.V., and Maron B.J. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49 (2007) 350-357
17. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 (2004) 1533-1542
18. Kramer C.M., Rogers Jr. W.J., Mankad S., Theobald T.M., Pakstis D.L., and Hu Y.L. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 36 (2000) 1835-1840
19. Gibbons R.J., Miller T.D., and Christian T.F. Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation 101 (2000) 101-108
20. Pellikka P.A., Behrenbeck T., Verani M.S., Mahmarian J.J., Wackers F.J., and Gibbons R.J. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarction. J Nucl Med 31 (1990) 1269-1275
21. Richard V., Murry C.E., and Reimer K.A. Healing of myocardial infarcts in dogs. Effects of late reperfusion. Circulation 92 (1995) 1891-1901
22. Holmes J.W., Yamashita H., Waldman L.K., and Covell J.W. Scar remodeling and transmural deformation after infarction in the pig. Circulation 90 (1994) 411-420
23. Jugdutt B.I. Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog. Can J Physiol Pharmacol 65 (1987) 307-316
24. Jugdutt B.I., and Amy R.W. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J Am Coll Cardiol 7 (1986) 91-102
25. Fishbein M.C., Maclean D., and Maroko P.R. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90 (1978) 57-70
26. Bora P.S., Kaliappan S., Xu Q., Kumar S., Wang Y., Kaplan H.J., and Bora N.S. Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularization. FEBS J 273 (2006) 1403-1414
27. Gu J.W., Bailey A.P., Sartin A., Makey I., and Brady A.L. Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos. Cancer 103 (2005) 422-431
28. Gupta S., Kobayashi S., Phongkitkarun S., Broemeling L.D., and Kan Z. Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model. Invest Radiol 41 (2006) 516-521
29. Liao X., Yi J., Li X., Yang Z., Deng W., and Tian G. Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization. J Huazhong Univ Sci Technolog Med Sci 23 (2003) 280-282
30. Liao X.F., Yi J.L., Li X.R., Deng W., Yang Z.F., and Tian G. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. World J Gastroenterol 10 (2004) 1885-1889